信息搜索
信息关键字:医药
 

共有1868条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94]

·《新型冠状病毒肺炎诊疗方案(试行第九版)》发布上海医药多项药物助力疫情防治2022-3-20 20:03:11
·主板IPO周报:青松医药“临门”撤材料弘业期货A股闯关成功2022-3-20 19:08:09
·天风策略:冰点过后是喘息窗口,继续推荐医药、汽车链条(附股债收益率差更新)2022-3-20 15:07:27
·医药生物:特色原料药:当困境反转的API遇上新冠特效药2022-3-20 13:36:04
·医药板块一季度业绩前瞻:不同领域景气度分化加剧2022-3-20 8:43:24
·《2022全球经济信心指数》调查:新能源、5G和物联网、智能网联汽车、生物医药位列今年前四大成长性行业2022-3-19 12:21:43
·集采或常态化中医药行业直面新挑战2022-3-19 5:16:49
·本月以来299家公司接受机构调研机构聚焦机械设备、医药生物等热门赛道2022-3-19 0:08:10
·全国首批新冠口服药Paxlovid通关,13只概念股业绩增长。锂电池、医药赛道资金现分歧2022-3-18 20:59:48
·恒瑞医药:子公司获得药物临床试验批准通知书相关项目已投入研发费用约3260万元2022-3-18 19:06:54
·龙虎榜:1.9亿抢筹中国医药外资净买3股机构净买4股2022-3-18 18:37:52
·复盘130涨停股:中国医药13天10板浙江建投4板美利云跌停2022-3-18 17:10:48
·民族品牌指数收跌0.39%上海医药涨停2022-3-18 16:45:51
·盘后机会挖掘汇总:中国医药再度涨停!中国平安领衔保险板块午后暴力拉升!2022-3-18 16:37:47
·医药生物“最吸睛”、高新制造“广撒网”这两个行业被理财资金盯上了2022-3-18 12:44:38
·上海医药两连板,创新药指ETF上涨0.73%2022-3-18 11:14:01
·年报披露加速业绩成机构评级主线;化工、医药板块获市场瞩目16只评级股上涨潜力超20%(附股)2022-3-17 20:13:23
·年报披露加速,业绩成机构评级主线;化工、医药板块获市场瞩目,16只评级股上涨潜力超20%(附股)2022-3-17 20:08:56
·容大感光20CM涨停却遭机构、北向资金齐齐净卖出还卖出这只医药股(名单)2022-3-17 19:50:11
·恒瑞医药将花不超12亿元回购公司股份用于员工持股计划2022-3-17 18:52:40

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94]